Dr Lalchandani Labs Stock Screener | Share Price & Fundamental Analysis
DLCL
Healthcare Service Provider
Screen Dr Lalchandani Labs share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹8.25 Cr.
P/B Ratio
0.76
EPS (TTM)
₹0.96
Dividend Yield
-
Debt to Equity
0.39
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹16.00
Total Equity
₹10.00
Dr Lalchandani Labs Share Price History - Stock Screener Chart
Screen DLCL historical share price movements with interactive charts. Analyze price trends and patterns.
Dr Lalchandani Labs Company Profile - Fundamental Screener
Screen Dr Lalchandani Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DLCL shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE871Z01013
Dr Lalchandani Labs Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen DLCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 16 | 15 | 18 | 18 | 15 | 12 | 10 | 6 |
| Current Assets | 11 | 10 | 11 | 11 | 9 | 8 | 6 | 4 |
| Fixed Assets | 4 | 4 | 5 | 6 | 5 | 4 | 3 | 2 |
| Liabilities | ||||||||
| Total Liabilities | 16 | 15 | 18 | 18 | 15 | 12 | 10 | 6 |
| Current Liabilities | 0 | 0 | 4 | 3 | 3 | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 10 | 10 | 9 | 11 | 10 | 9 | 8 | 3 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Reserves & Surplus | 6 | 5 | 5 | 6 | 5 | 4 | 4 | 0 |
Screen DLCL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 5 | 5 | 5 | 11 | 10 | 6 | 5 | 3 |
| Expenses | 0 | 4 | 5 | 5 | 9 | 8 | 5 | 4 | 2 |
| EBITDA | 0 | 1 | 0 | 0 | 2 | 2 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | 21.00% | 4.00% | 2.00% | 21.00% | 23.00% | 21.00% | 23.00% | 22.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | -2 | 1 | 1 | 1 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | -2 | 1 | 1 | 1 | 1 | 0 |
| EPS | 0.00 | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 | 1.09 | 1.23 | 0.89 |
Dr Lalchandani Labs Cash Flow Screener - Liquidity Fundamentals
Screen DLCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 1 |
| Investing Activities | 0 | 1 | 0 | -2 | -2 | -1 | -2 | -1 |
| Financing Activities | 1 | -2 | 0 | 0 | 2 | 1 | 4 | 2 |
| Net Cash Flow | 1 | -1 | 0 | 1 | 1 | 0 | 1 | 1 |
Screen DLCL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept | 2023-Mar | 2022-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.15% | 48.32% | 57.18% | 60.78% | 60.78% | 60.78% | 60.78% | 60.78% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 64.51% | 45.68% | 36.54% | 32.94% | 33.03% | 32.75% | 34.32% | 33.58% |
| Other Holding | 4.34% | 6.00% | 6.28% | 6.28% | 6.18% | 6.46% | 4.89% | 5.63% |
| Shareholder Count | 206 | 246 | 181 | 165 | 159 | 162 | 157 | 151 |
Dr Lalchandani Labs Dividend Screener - Share Yield Analysis
Screen DLCL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Dr Lalchandani Labs Index Membership - Market Screener Classification
Screen DLCL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Dr Lalchandani Labs Market Events Screener - Corporate Actions
Screen DLCL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -9.35% | ||
| Annual General Meeting | NA | -12.62% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.98% |
| 2025-05-01 | 2025-05-01 | Quarterly Result Announcement | NA | -6.09% |
| 2024-10-14 | 2024-10-14 | Quarterly Result Announcement | NA | 5.18% |
Dr Lalchandani Labs Competitors Screener - Peer Comparison
Screen DLCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,588 | 43.78 | 2,555 | 11.28% | 492 | 32.49 |
| Vijaya Diagnostic Centre | 10,584 | 68.56 | 700 | 23.06% | 144 | 56.57 |
| Metropolis Healthcare | 9,778 | 62.09 | 1,346 | 10.64% | 146 | 39.96 |
| Thyrocare Technologies | 7,200 | 57.36 | 702 | 20.80% | 91 | 50.72 |
| Nephrocare Health Services | 4,770 | 69.25 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,365 | 28.02 | 743 | 16.70% | 78 | 39.66 |
| Suraksha Diagnostic | 1,415 | 45.85 | 256 | 15.11% | 31 | 33.48 |
| One Global Service Provider | 1,273 | 27.75 | 148 | 134.60% | 19 | 64.86 |
| 3B BlackBio DX | 1,256 | 25.22 | 112 | 28.72% | 48 | 64.75 |
| Sastasundar Ventures | 961 | -107.11 | 1,171 | -18.47% | -134 | 45.71 |
Dr Lalchandani Labs Company Announcements - News Screener
Screen DLCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Board Meeting Outcome for Intimation Of Deferment Of Board Meeting Scheduled On December 22 2025 | View |
| 2025-12-31 | Board Meeting Intimation for Fund Raising | View |
| 2025-12-29 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2025-12-29 | Board Meeting Outcome for Outcome Of Board Meeting Held On December 15 2025 | View |
| 2025-12-09 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-12-02 | Board Meeting Intimation for Considering Of Raising Of Funds Through A Rights Issue And/Or Any Other Permissible Mode | View |
| 2025-11-14 | Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 2025 | View |
| 2025-11-14 | Unaudited Financials Results For The Half Year Ended September 30 2025 | View |
| 2025-11-10 | Board Meeting Intimation for Consider And Approve Financial Statements For The Half Year Ended 30.09.2025 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-06 | Notice Of 08Th Annual General Meeting Of The Company | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Book Closure For The Purpose Of 08Th Annual General Meeting Of The Company | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-05 | Appointment Of M/S Chauhan Pradeep & Associates As Secretarial Auditor Of The Company For The Period Of 5 Years | View |
| 2025-09-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. September 05 2025 | View |